Literature DB >> 22535835

Effect of hydrocortisone on the production and glycosylation of an Fc-fusion protein in CHO cell cultures.

Yolande Rouiller1, Arnaud Périlleux, Milène Marsaut, Matthieu Stettler, Marie-Noëlle Vesin, Hervé Broly.   

Abstract

Glucocorticoids are known to modulate various cellular functions such as cell proliferation, metabolism, glycosylation, and secretion of many proteins. We tested the effect of hydrocortisone (HC) on cell growth, viability, metabolism, protein production, and glycosylation of an Fc-protein expressing Chinese hamster ovary (CHO) cell culture. HC extended cell viability but impaired cell growth. The inhibitory effect on cell growth was dose-dependent and decreased when the glucocorticoid addition was delayed. When HC was added after 2 or 3 days of culture, an increase in glutamate consumption was observed, which was reversed by the glucocorticoid receptor antagonist mifepristone (Mif). Titer and specific productivity increased in the presence of HC. The increase in titer was only slightly reversed by Mif. On the other hand, Mif by itself induced an increase in titer to a level comparable to or higher than HC. Protein glycosylation was altered by the glucocorticoid in a dose- and time-dependent manner, with a shift to more acidic bands, which correlated with an increase in sialic acid moieties. This increase, which was not linked to a decrease in extracellular sialidase activity in HC-treated cultures, was reversed by Mif. Predictive models based on design of experiments enabled the definition of optimal conditions for process performance in terms of viability and titer and for the quality of the Fc-fusion protein in terms of glycosylation. The data obtained suggest a use of glucocorticoids for commercial production of Fc-fusion proteins expressed in CHO cells.
Copyright © 2012 American Institute of Chemical Engineers (AIChE).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535835     DOI: 10.1002/btpr.1530

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  6 in total

1.  Galactose supplementation enhance sialylation of recombinant Fc-fusion protein in CHO cell: an insight into the role of galactosylation in sialylation.

Authors:  Jintao Liu; Jie Wang; Li Fan; Xinning Chen; Dongdong Hu; Xiancun Deng; H Fai Poon; Haibin Wang; Xuping Liu; Wen-Song Tan
Journal:  World J Microbiol Biotechnol       Date:  2015-05-01       Impact factor: 3.312

2.  Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.

Authors:  J Stümer; M H C Biermann; J Knopf; I Magorivska; A Kastbom; A Svärd; C Janko; R Bilyy; G Schett; C Sjöwall; M Herrmann; L E Muñoz
Journal:  Clin Exp Immunol       Date:  2017-06-13       Impact factor: 4.330

3.  The sialoglycan-Siglec-E checkpoint axis in dexamethasone-induced immune subversion in glioma-microglia transwell co-culture system.

Authors:  Przemyslaw Wielgat; Robert Czarnomysy; Emil Trofimiuk; Halina Car
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 4.  Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components

Authors:  Fatemeh Torkashvand; Behrouz Vaziri
Journal:  Iran Biomed J       Date:  2017-04-20

5.  IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.

Authors:  Susanna L Lundström; Aase H Hensvold; Dorothea Rutishauser; Lars Klareskog; A Jimmy Ytterberg; Roman A Zubarev; Anca I Catrina
Journal:  Arthritis Res Ther       Date:  2017-08-09       Impact factor: 5.156

6.  Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease.

Authors:  Tina Heyder; Emil Wiklundh; Anders Eklund; Anna James; Johan Grunewald; Roman A Zubarev; Susanna L Lundström
Journal:  ERJ Open Res       Date:  2018-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.